<DOC>
	<DOCNO>NCT00958308</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Bio-K+ CL-1285 prevention Antibiotic-Associated Diarrhea ( AAD ) Clostridum difficile-Associated Diarrhea ( CDAD ) hospitalize patient expose nosocomial infection .</brief_summary>
	<brief_title>Efficacy Safety Study Prevention Antibiotic-Associated Diarrhea ( AAD ) Clostridium Difficile-Associated Diarrhea ( CDAD ) Hospitalized Adult Patients Exposed Nosocomial Infection</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Antibiotic therapy minimum 3 day maximum 14 day Expected remain hospitalized minimum 5 day Patients receive less 36 hour antibiotic therapy Negative pregnancy test screening Obtained his/her informed consent verbal write information Patients telephone available ( mobile , work , home ) Patients fridge home Pregnant breastfeed woman Patients present active diarrhea ( 3 liquid stool per 24 hour period ) . Patients history daily consumption probiotic , ferment milk and/or yogurt ; Patients know show previous reaction , include anaphylaxis , substance composition study product ( i.e . Nonmedicinal ingredient : Cellulose , hypromellose , magnesium stearate ( vegetal source ) , ascorbic acid , Colloidal silicon dioxide ) Patients present active , noncontrolled intestinal disease Crohn 's Disease ulcerative colitis ; A previous document C. Difficile infection &lt; 3 month prior study initiation ; Ostomized patient , parenteral nutrition user Patients immunosuppressive therapy health condition cause immunosuppression ( include haematological malignancy , acquire immune deficiency syndrome ( AIDS ) ) Ongoing recent use antibiotic therapy 30 day prior study product first administration . Patients plan administration antibiotic broad spectrum Penicillin , Cephalosporin Clindamycin treatment infection ; Patients concomitant participation another clinical trial ; Patients likely comply study requirement</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Probiotic</keyword>
	<keyword>Antibiotic-Associated Diarrhea ( AAD ) Prevention</keyword>
	<keyword>Clostridium Difficile-Associated Diarrhea ( CDAD ) Prevention</keyword>
</DOC>